_SLIDE_1_
Ursa complex soft cap.
_SLIDE_2_
Index
1. Introduction
2. SWOT Analysis
3. Marketing Activity
4. Conclusion
_SLIDE_3_
Introduction
Part01
_SLIDE_4_
+
Company Logo
ÓÞ
ê¨
_SLIDE_5_
Company Profile
¡Ý CEO : Lee, Jong Wook
¡Ý Established in 1945,
Daewoong Pharmaceutical Co., Ltd
¡Ý Market Capitalization : 527 billion
(Dec.2xxx, KRW)
¡Ý Employees : 1,250
¡Ý Sales : 672 billion (Dec.2xxx, KRW)
¡Ý Branches : 14 (Korea) 7 (Asia) 1(America)
VISION
A Global Healthcare Group leading improvement in the quality of life!
_SLIDE_6_
Product - Ursa
Improvement of
hepatic function
_SLIDE_7_
SWOT Analysis
Part02
_SLIDE_8_
SWOT Analysis
Power of Brand Image
Easy to Purchase
- Hot Issue on Liver Health
- Well-being Age
- High Advertising Costs
- Limited Target
- Keen Competition
- Alternative Drug Market
Weakness
Strength
Threat
Opportunity
SWOT Analysis
_SLIDE_9_
Marketing Strategy -Ads
Part03
_SLIDE_10_
History ¡¦(»ý·«)
|
- CM song linking fun!
_SLIDE_17_
Point 3. Powerful Message
Easy to Memory and Repetitive Message. (About Liver Health)
Because of Liver!
Because of Liver!
Be ~ Cause~
Because of Liver!
_SLIDE_18_
Point 4. Novelty
Stimuli Selection Factors :
Novelty
_SLIDE_19_
Point 5.
Low to High Involvement
Shifting Consumers from Low to High Involvement.
Needs
_SLIDE_20_
Thank you
_NOTES_1_
1